Open AccessThe Incidental prostatic adenocarcinoma and transitional cell carcinoma involvement of the prostate gland in patients undergoing radical cystoprostatectomy for bladder cancer treatment in Rajavithi Hospital
Author(s) -
Weerawut Promwattanapan,
AUTHOR_ID,
Nattapong Wongwattanasatien,
AUTHOR_ID
Publication year - 2021
Publication title -
insight urology
Language(s) - English
Resource type - Journals
ISSN - 2730-3217
DOI - 10.52786/isu.a.31
Subject(s) - medicine , cystoprostatectomy , urology , prostate , stage (stratigraphy) , adenocarcinoma , transitional cell carcinoma , cystectomy , prostate cancer , prostatectomy , cancer , neck of urinary bladder , prostatic urethra , bladder cancer , urinary bladder , paleontology , biology
Objective: To determine the incidence of incidental prostatic adenocarcinoma and transitional cell carcinoma (TCC) involvement of the prostate gland in patients undergoing radical cystoprostatectomy in Rajavithi Hospital, Secondly, to assess the possible influence of the patient factors and bladder cancer on the pathological findings of the prostate gland. Materials and Methods: We retrospectively reviewed 169 male patients who had undergone radical cystoprostatectomy for bladder cancer between April 2013 and August 2019. Pathologic findings of the prostate gland and urothelial cancer in the prostate gland were catalogued. Information including age, body mass index (BMI), underlying disease, glomerular filtration rate (GFR), pathologic stage, and grade was collected and analyzed to determine any correlations. Results: Incidental prostatic adenocarcinoma and TCC involvement of the prostate gland were found in 15 patients (8.9%) and 29 patients (17.2%), respectively. There were no correlations between patient demographics and pathological findings of the prostate gland. Conclusion: Although the incidence of incidental prostatic adenocarcinoma and TCC involvement of the prostate gland in our research is low, the screening of every candidate for prostate sparing cystectomy with a digital rectal examination, prostate-specific antigen, and transurethral biopsy of the prostatic urethra and bladder neck prior to surgery are recommended.